 | • レポートコード：D0804-16188 • 出版社/出版日：GlobalInfoResearch / 2020年7月28日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、106ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、新抗ウイルス薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。新抗ウイルス薬の種類別市場規模（逆転写酵素阻害剤、プロテアーゼ阻害剤、融合阻害剤、免疫系調節剤、その他）、用途別市場規模（肝炎治療学、HIV・AIDS治療学、ヘルペス治療学、インフルエンザ治療学、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Roche Holding AG、Dr Reddy’s、AbbVie、GlaxoSmithKline、Novartis、Bristol-Myers Squibb、Aurobindo Pharma、Merck & Co、Johnson & Johnson、Gilead Sciences、Cipla ・地域別グローバル市場分析 2015年-2020年 ・新抗ウイルス薬の北米市場（アメリカ、カナダ、メキシコ） ・新抗ウイルス薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・新抗ウイルス薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・新抗ウイルス薬の南米市場（ブラジル、アルゼンチン） ・新抗ウイルス薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：逆転写酵素阻害剤、プロテアーゼ阻害剤、融合阻害剤、免疫系調節剤、その他 ・用途別分析：肝炎治療学、HIV・AIDS治療学、ヘルペス治療学、インフルエンザ治療学、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Novel Antiviral Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Novel Antiviral Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Novel Antiviral Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Novel Antiviral Drugs market has been segmented into:
Reverse Transcriptase Inhibitors
Protease Inhibitors
Fusion Inhibitors
Immune System Modulators
Other
By Application, Novel Antiviral Drugs has been segmented into:
Hepatitis Therapeutics
HIV/AIDS Therapeutics
Herpes Therapeutics
Influenza Therapeutics
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Novel Antiviral Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Novel Antiviral Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Novel Antiviral Drugs market.
The report offers in-depth assessment of the growth and other aspects of the Novel Antiviral Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Novel Antiviral Drugs Market Share Analysis
Novel Antiviral Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Novel Antiviral Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Novel Antiviral Drugs sales, revenue and market share for each player covered in this report.
The major players covered in Novel Antiviral Drugs are:
Roche Holding AG
Dr Reddy’s
AbbVie
GlaxoSmithKline
Novartis
Bristol-Myers Squibb
Aurobindo Pharma
Merck & Co
Johnson & Johnson
Gilead Sciences
Cipla
Table of Contents
1 Novel Antiviral Drugs Market Overview
1.1 Product Overview and Scope of Novel Antiviral Drugs
1.2 Classification of Novel Antiviral Drugs by Type
1.2.1 Global Novel Antiviral Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Novel Antiviral Drugs Revenue Market Share by Type in 2019
1.2.3 Reverse Transcriptase Inhibitors
1.2.4 Protease Inhibitors
1.2.5 Fusion Inhibitors
1.2.6 Immune System Modulators
1.2.7 Other
1.3 Global Novel Antiviral Drugs Market by Application
1.3.1 Overview: Global Novel Antiviral Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hepatitis Therapeutics
1.3.3 HIV/AIDS Therapeutics
1.3.4 Herpes Therapeutics
1.3.5 Influenza Therapeutics
1.3.6 Other
1.4 Global Novel Antiviral Drugs Market by Regions
1.4.1 Global Novel Antiviral Drugs Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Novel Antiviral Drugs (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Novel Antiviral Drugs Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Novel Antiviral Drugs Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Novel Antiviral Drugs Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Novel Antiviral Drugs Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Novel Antiviral Drugs Status and Prospect (2015-2025)
2 Company Profiles
2.1 Roche Holding AG
2.1.1 Roche Holding AG Details
2.1.2 Roche Holding AG Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Roche Holding AG SWOT Analysis
2.1.4 Roche Holding AG Product and Services
2.1.5 Roche Holding AG Novel Antiviral Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.2 Dr Reddy’s
2.2.1 Dr Reddy’s Details
2.2.2 Dr Reddy’s Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Dr Reddy’s SWOT Analysis
2.2.4 Dr Reddy’s Product and Services
2.2.5 Dr Reddy’s Novel Antiviral Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.3 AbbVie
2.3.1 AbbVie Details
2.3.2 AbbVie Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 AbbVie SWOT Analysis
2.3.4 AbbVie Product and Services
2.3.5 AbbVie Novel Antiviral Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.4 GlaxoSmithKline
2.4.1 GlaxoSmithKline Details
2.4.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 GlaxoSmithKline SWOT Analysis
2.4.4 GlaxoSmithKline Product and Services
2.4.5 GlaxoSmithKline Novel Antiviral Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.5 Novartis
2.5.1 Novartis Details
2.5.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Novartis SWOT Analysis
2.5.4 Novartis Product and Services
2.5.5 Novartis Novel Antiviral Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.6 Bristol-Myers Squibb
2.6.1 Bristol-Myers Squibb Details
2.6.2 Bristol-Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Bristol-Myers Squibb SWOT Analysis
2.6.4 Bristol-Myers Squibb Product and Services
2.6.5 Bristol-Myers Squibb Novel Antiviral Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.7 Aurobindo Pharma
2.7.1 Aurobindo Pharma Details
2.7.2 Aurobindo Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Aurobindo Pharma SWOT Analysis
2.7.4 Aurobindo Pharma Product and Services
2.7.5 Aurobindo Pharma Novel Antiviral Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.8 Merck & Co
2.8.1 Merck & Co Details
2.8.2 Merck & Co Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Merck & Co SWOT Analysis
2.8.4 Merck & Co Product and Services
2.8.5 Merck & Co Novel Antiviral Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.9 Johnson & Johnson
2.9.1 Johnson & Johnson Details
2.9.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Johnson & Johnson SWOT Analysis
2.9.4 Johnson & Johnson Product and Services
2.9.5 Johnson & Johnson Novel Antiviral Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.10 Gilead Sciences
2.10.1 Gilead Sciences Details
2.10.2 Gilead Sciences Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Gilead Sciences SWOT Analysis
2.10.4 Gilead Sciences Product and Services
2.10.5 Gilead Sciences Novel Antiviral Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.11 Cipla
2.11.1 Cipla Details
2.11.2 Cipla Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Cipla SWOT Analysis
2.11.4 Cipla Product and Services
2.11.5 Cipla Novel Antiviral Drugs Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Novel Antiviral Drugs Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Novel Antiviral Drugs Players Market Share
3.2.2 Top 10 Novel Antiviral Drugs Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Novel Antiviral Drugs Revenue and Market Share by Regions
4.2 North America Novel Antiviral Drugs Revenue and Growth Rate (2015-2020)
4.3 Europe Novel Antiviral Drugs Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Novel Antiviral Drugs Revenue and Growth Rate (2015-2020)
4.5 South America Novel Antiviral Drugs Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Novel Antiviral Drugs Revenue and Growth Rate (2015-2020)
5 North America Novel Antiviral Drugs Revenue by Countries
5.1 North America Novel Antiviral Drugs Revenue by Countries (2015-2020)
5.2 USA Novel Antiviral Drugs Revenue and Growth Rate (2015-2020)
5.3 Canada Novel Antiviral Drugs Revenue and Growth Rate (2015-2020)
5.4 Mexico Novel Antiviral Drugs Revenue and Growth Rate (2015-2020)
6 Europe Novel Antiviral Drugs Revenue by Countries
6.1 Europe Novel Antiviral Drugs Revenue by Countries (2015-2020)
6.2 Germany Novel Antiviral Drugs Revenue and Growth Rate (2015-2020)
6.3 UK Novel Antiviral Drugs Revenue and Growth Rate (2015-2020)
6.4 France Novel Antiviral Drugs Revenue and Growth Rate (2015-2020)
6.5 Russia Novel Antiviral Drugs Revenue and Growth Rate (2015-2020)
6.6 Italy Novel Antiviral Drugs Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Novel Antiviral Drugs Revenue by Countries
7.1 Asia-Pacific Novel Antiviral Drugs Revenue by Countries (2015-2020)
7.2 China Novel Antiviral Drugs Revenue and Growth Rate (2015-2020)
7.3 Japan Novel Antiviral Drugs Revenue and Growth Rate (2015-2020)
7.4 Korea Novel Antiviral Drugs Revenue and Growth Rate (2015-2020)
7.5 India Novel Antiviral Drugs Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Novel Antiviral Drugs Revenue and Growth Rate (2015-2020)
8 South America Novel Antiviral Drugs Revenue by Countries
8.1 South America Novel Antiviral Drugs Revenue by Countries (2015-2020)
8.2 Brazil Novel Antiviral Drugs Revenue and Growth Rate (2015-2020)
8.3 Argentina Novel Antiviral Drugs Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Novel Antiviral Drugs by Countries
9.1 Middle East & Africa Novel Antiviral Drugs Revenue by Countries (2015-2020)
9.2 Saudi Arabia Novel Antiviral Drugs Revenue and Growth Rate (2015-2020)
9.3 UAE Novel Antiviral Drugs Revenue and Growth Rate (2015-2020)
9.4 Egypt Novel Antiviral Drugs Revenue and Growth Rate (2015-2020)
9.5 South Africa Novel Antiviral Drugs Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Novel Antiviral Drugs Revenue and Market Share by Type (2015-2020)
10.2 Global Novel Antiviral Drugs Market Forecast by Type (2019-2024)
10.3 Reverse Transcriptase Inhibitors Revenue Growth Rate (2015-2025)
10.4 Protease Inhibitors Revenue Growth Rate (2015-2025)
10.5 Fusion Inhibitors Revenue Growth Rate (2015-2025)
10.6 Immune System Modulators Revenue Growth Rate (2015-2025)
10.7 Other Revenue Growth Rate (2015-2025)
11 Global Novel Antiviral Drugs Market Segment by Application
11.1 Global Novel Antiviral Drugs Revenue Market Share by Application (2015-2020)
11.2 Novel Antiviral Drugs Market Forecast by Application (2019-2024)
11.3 Hepatitis Therapeutics Revenue Growth (2015-2020)
11.4 HIV/AIDS Therapeutics Revenue Growth (2015-2020)
11.5 Herpes Therapeutics Revenue Growth (2015-2020)
11.6 Influenza Therapeutics Revenue Growth (2015-2020)
11.7 Other Revenue Growth (2015-2020)
12 Global Novel Antiviral Drugs Market Size Forecast (2021-2025)
12.1 Global Novel Antiviral Drugs Market Size Forecast (2021-2025)
12.2 Global Novel Antiviral Drugs Market Forecast by Regions (2021-2025)
12.3 North America Novel Antiviral Drugs Revenue Market Forecast (2021-2025)
12.4 Europe Novel Antiviral Drugs Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Novel Antiviral Drugs Revenue Market Forecast (2021-2025)
12.6 South America Novel Antiviral Drugs Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Novel Antiviral Drugs Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Novel Antiviral Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Novel Antiviral Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Novel Antiviral Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Novel Antiviral Drugs Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Roche Holding AG Corporate Information, Location and Competitors
Table 6. Roche Holding AG Novel Antiviral Drugs Major Business
Table 7. Roche Holding AG Novel Antiviral Drugs Total Revenue (USD Million) (2017-2018)
Table 8. Roche Holding AG SWOT Analysis
Table 9. Roche Holding AG Novel Antiviral Drugs Product and Solutions
Table 10. Roche Holding AG Novel Antiviral Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Dr Reddy’s Corporate Information, Location and Competitors
Table 12. Dr Reddy’s Novel Antiviral Drugs Major Business
Table 13. Dr Reddy’s Novel Antiviral Drugs Total Revenue (USD Million) (2018-2019)
Table 14. Dr Reddy’s SWOT Analysis
Table 15. Dr Reddy’s Novel Antiviral Drugs Product and Solutions
Table 16. Dr Reddy’s Novel Antiviral Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. AbbVie Corporate Information, Location and Competitors
Table 18. AbbVie Novel Antiviral Drugs Major Business
Table 19. AbbVie Novel Antiviral Drugs Total Revenue (USD Million) (2017-2018)
Table 20. AbbVie SWOT Analysis
Table 21. AbbVie Novel Antiviral Drugs Product and Solutions
Table 22. AbbVie Novel Antiviral Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. GlaxoSmithKline Corporate Information, Location and Competitors
Table 24. GlaxoSmithKline Novel Antiviral Drugs Major Business
Table 25. GlaxoSmithKline Novel Antiviral Drugs Total Revenue (USD Million) (2017-2018)
Table 26. GlaxoSmithKline SWOT Analysis
Table 27. GlaxoSmithKline Novel Antiviral Drugs Product and Solutions
Table 28. GlaxoSmithKline Novel Antiviral Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Novartis Corporate Information, Location and Competitors
Table 30. Novartis Novel Antiviral Drugs Major Business
Table 31. Novartis Novel Antiviral Drugs Total Revenue (USD Million) (2017-2018)
Table 32. Novartis SWOT Analysis
Table 33. Novartis Novel Antiviral Drugs Product and Solutions
Table 34. Novartis Novel Antiviral Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Bristol-Myers Squibb Corporate Information, Location and Competitors
Table 36. Bristol-Myers Squibb Novel Antiviral Drugs Major Business
Table 37. Bristol-Myers Squibb Novel Antiviral Drugs Total Revenue (USD Million) (2017-2018)
Table 38. Bristol-Myers Squibb SWOT Analysis
Table 39. Bristol-Myers Squibb Novel Antiviral Drugs Product and Solutions
Table 40. Bristol-Myers Squibb Novel Antiviral Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Aurobindo Pharma Corporate Information, Location and Competitors
Table 42. Aurobindo Pharma Novel Antiviral Drugs Major Business
Table 43. Aurobindo Pharma Novel Antiviral Drugs Total Revenue (USD Million) (2017-2018)
Table 44. Aurobindo Pharma SWOT Analysis
Table 45. Aurobindo Pharma Novel Antiviral Drugs Product and Solutions
Table 46. Aurobindo Pharma Novel Antiviral Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Merck & Co Corporate Information, Location and Competitors
Table 48. Merck & Co Novel Antiviral Drugs Major Business
Table 49. Merck & Co Novel Antiviral Drugs Total Revenue (USD Million) (2017-2018)
Table 50. Merck & Co SWOT Analysis
Table 51. Merck & Co Novel Antiviral Drugs Product and Solutions
Table 52. Merck & Co Novel Antiviral Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Johnson & Johnson Corporate Information, Location and Competitors
Table 54. Johnson & Johnson Novel Antiviral Drugs Major Business
Table 55. Johnson & Johnson Novel Antiviral Drugs Total Revenue (USD Million) (2017-2018)
Table 56. Johnson & Johnson SWOT Analysis
Table 57. Johnson & Johnson Novel Antiviral Drugs Product and Solutions
Table 58. Johnson & Johnson Novel Antiviral Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Gilead Sciences Corporate Information, Location and Competitors
Table 60. Gilead Sciences Novel Antiviral Drugs Major Business
Table 61. Gilead Sciences Novel Antiviral Drugs Total Revenue (USD Million) (2017-2018)
Table 62. Gilead Sciences SWOT Analysis
Table 63. Gilead Sciences Novel Antiviral Drugs Product and Solutions
Table 64. Gilead Sciences Novel Antiviral Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Cipla Corporate Information, Location and Competitors
Table 66. Cipla Novel Antiviral Drugs Major Business
Table 67. Cipla Novel Antiviral Drugs Total Revenue (USD Million) (2017-2018)
Table 68. Cipla SWOT Analysis
Table 69. Cipla Novel Antiviral Drugs Product and Solutions
Table 70. Cipla Novel Antiviral Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Global Novel Antiviral Drugs Revenue (Million USD) by Players (2015-2020)
Table 72. Global Novel Antiviral Drugs Revenue Share by Players (2015-2020)
Table 73. Global Novel Antiviral Drugs Revenue (Million USD) by Regions (2015-2020)
Table 74. Global Novel Antiviral Drugs Revenue Market Share by Regions (2015-2020)
Table 75. North America Novel Antiviral Drugs Revenue by Countries (2015-2020)
Table 76. North America Novel Antiviral Drugs Revenue Market Share by Countries (2015-2020)
Table 77. Europe Novel Antiviral Drugs Revenue (Million USD) by Countries (2015-2020)
Table 78. Asia-Pacific Novel Antiviral Drugs Revenue (Million USD) by Countries (2015-2020)
Table 79. South America Novel Antiviral Drugs Revenue by Countries (2015-2020)
Table 80. South America Novel Antiviral Drugs Revenue Market Share by Countries (2015-2020)
Table 81. Middle East and Africa Novel Antiviral Drugs Revenue (Million USD) by Countries (2015-2020)
Table 82. Middle East and Africa Novel Antiviral Drugs Revenue Market Share by Countries (2015-2020)
Table 83. Global Novel Antiviral Drugs Revenue (Million USD) by Type (2015-2020)
Table 84. Global Novel Antiviral Drugs Revenue Share by Type (2015-2020)
Table 85. Global Novel Antiviral Drugs Revenue Forecast by Type (2021-2025)
Table 86. Global Novel Antiviral Drugs Revenue by Application (2015-2020)
Table 87. Global Novel Antiviral Drugs Revenue Share by Application (2015-2020)
Table 88. Global Novel Antiviral Drugs Revenue Forecast by Application (2021-2025)
Table 89. Global Novel Antiviral Drugs Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Novel Antiviral Drugs Picture
Figure 2. Global Novel Antiviral Drugs Revenue Market Share by Type in 2019
Figure 3. Reverse Transcriptase Inhibitors Picture
Figure 4. Protease Inhibitors Picture
Figure 5. Fusion Inhibitors Picture
Figure 6. Immune System Modulators Picture
Figure 7. Other Picture
Figure 8. Novel Antiviral Drugs Revenue Market Share by Application in 2019
Figure 9. Hepatitis Therapeutics Picture
Figure 10. HIV/AIDS Therapeutics Picture
Figure 11. Herpes Therapeutics Picture
Figure 12. Influenza Therapeutics Picture
Figure 13. Other Picture
Figure 14. Global Novel Antiviral Drugs Revenue (USD Million) and Growth Rate (2015-2025)
Figure 15. North America Novel Antiviral Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Europe Novel Antiviral Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Asia-Pacific Novel Antiviral Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. South America Novel Antiviral Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Middle East and Africa Novel Antiviral Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Global Novel Antiviral Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 21. Global Novel Antiviral Drugs Revenue Share by Players in 2019
Figure 22. Global Top 5 Players Novel Antiviral Drugs Revenue Market Share in 2019
Figure 23. Global Top 10 Players Novel Antiviral Drugs Revenue Market Share in 2019
Figure 24. Key Players Market Share Trend
Figure 25. Global Novel Antiviral Drugs Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 26. Global Novel Antiviral Drugs Revenue Market Share by Regions (2015-2020)
Figure 27. Global Novel Antiviral Drugs Revenue Market Share by Regions in 2018
Figure 28. North America Novel Antiviral Drugs Revenue and Growth Rate (2015-2020)
Figure 29. Europe Novel Antiviral Drugs Revenue and Growth Rate (2015-2020)
Figure 30. Asia-Pacific Novel Antiviral Drugs Revenue and Growth Rate (2015-2020)
Figure 31. South America Novel Antiviral Drugs Revenue and Growth Rate (2015-2020)
Figure 32. Middle East and Africa Novel Antiviral Drugs Revenue and Growth Rate (2015-2020)
Figure 33. North America Novel Antiviral Drugs Revenue Market Share by Countries (2015-2020)
Figure 34. North America Novel Antiviral Drugs Revenue Market Share by Countries in 2019
Figure 35. USA Novel Antiviral Drugs Revenue and Growth Rate (2015-2020)
Figure 36. Canada Novel Antiviral Drugs Revenue and Growth Rate (2015-2020)
Figure 37. Mexico Novel Antiviral Drugs Revenue and Growth Rate (2015-2020)
Figure 38. Europe Novel Antiviral Drugs Revenue Market Share by Countries (2015-2020)
Figure 39. Europe Novel Antiviral Drugs Revenue Market Share by Countries in 2019
Figure 40. Germany Novel Antiviral Drugs Revenue and Growth Rate (2015-2020)
Figure 41. UK Novel Antiviral Drugs Revenue and Growth Rate (2015-2020)
Figure 42. France Novel Antiviral Drugs Revenue and Growth Rate (2015-2020)
Figure 43. Russia Novel Antiviral Drugs Revenue and Growth Rate (2015-2020)
Figure 44. Italy Novel Antiviral Drugs Revenue and Growth Rate (2015-2020)
Figure 45. Asia-Pacific Novel Antiviral Drugs Revenue Market Share by Countries (2015-2020)
Figure 46. Asia-Pacific Novel Antiviral Drugs Revenue Market Share by Countries in 2019
Figure 47. China Novel Antiviral Drugs Revenue and Growth Rate (2015-2020)
Figure 48. Japan Novel Antiviral Drugs Revenue and Growth Rate (2015-2020)
Figure 49. Korea Novel Antiviral Drugs Revenue and Growth Rate (2015-2020)
Figure 50. India Novel Antiviral Drugs Revenue and Growth Rate (2015-2020)
Figure 51. Southeast Asia Novel Antiviral Drugs Revenue and Growth Rate (2015-2020)
Figure 52. South America Novel Antiviral Drugs Revenue Market Share by Countries (2015-2020)
Figure 53. South America Novel Antiviral Drugs Revenue Market Share by Countries in 2019
Figure 54. Brazil Novel Antiviral Drugs Revenue and Growth Rate (2015-2020)
Figure 55. Argentina Novel Antiviral Drugs Revenue and Growth Rate (2015-2020)
Figure 56. Middle East and Africa Novel Antiviral Drugs Revenue Market Share by Countries (2015-2020)
Figure 57. Middle East and Africa Novel Antiviral Drugs Revenue Market Share by Countries in 2019
Figure 58. Saudi Arabia Novel Antiviral Drugs Revenue and Growth Rate (2015-2020)
Figure 59. UAE Novel Antiviral Drugs Revenue and Growth Rate (2015-2020)
Figure 60. Egypt Novel Antiviral Drugs Revenue and Growth Rate (2015-2020)
Figure 61. South Africa Novel Antiviral Drugs Revenue and Growth Rate (2015-2020)
Figure 62. Global Novel Antiviral Drugs Revenue Share by Type (2015-2020)
Figure 63. Global Novel Antiviral Drugs Revenue Share by Type in 2019
Figure 64. Global Novel Antiviral Drugs Market Share Forecast by Type (2021-2025)
Figure 65. Global Reverse Transcriptase Inhibitors Revenue Growth Rate (2015-2020)
Figure 66. Global Protease Inhibitors Revenue Growth Rate (2015-2020)
Figure 67. Global Fusion Inhibitors Revenue Growth Rate (2015-2020)
Figure 68. Global Immune System Modulators Revenue Growth Rate (2015-2020)
Figure 69. Global Other Revenue Growth Rate (2015-2020)
Figure 70. Global Novel Antiviral Drugs Revenue Share by Application (2015-2020)
Figure 71. Global Novel Antiviral Drugs Revenue Share by Application in 2019
Figure 72. Global Novel Antiviral Drugs Market Share Forecast by Application (2021-2025)
Figure 73. Global Hepatitis Therapeutics Revenue Growth Rate (2015-2020)
Figure 74. Global HIV/AIDS Therapeutics Revenue Growth Rate (2015-2020)
Figure 75. Global Herpes Therapeutics Revenue Growth Rate (2015-2020)
Figure 76. Global Influenza Therapeutics Revenue Growth Rate (2015-2020)
Figure 77. Global Other Revenue Growth Rate (2015-2020)
Figure 78. Global Novel Antiviral Drugs Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 79. Global Novel Antiviral Drugs Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 80. Global Novel Antiviral Drugs Revenue Market Share Forecast by Regions (2021-2025)
Figure 81. North America Novel Antiviral Drugs Revenue Market Forecast (2021-2025)
Figure 82. Europe Novel Antiviral Drugs Revenue Market Forecast (2021-2025)
Figure 83. Asia-Pacific Novel Antiviral Drugs Revenue Market Forecast (2021-2025)
Figure 84. South America Novel Antiviral Drugs Revenue Market Forecast (2021-2025)
Figure 85. Middle East and Africa Novel Antiviral Drugs Revenue Market Forecast (2021-2025)
Figure 86. Sales Channel: Direct Channel vs Indirect Channel
直接作用型抗ウイルス薬の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Direct-acting Antiviral Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Direct-acting A…- 抗ウイルス治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Antiviral Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Antiviral Therapeutics…
- 抗肝炎ウイルス薬の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The Anti Hepatitis Virus Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiza…
- スフィンゴシン-1-受容体調節薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The Sphingosine-1-Receptor Modulators Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value c…
- 乾癬性関節炎治療薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Psoriatic Arthritis Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Psoriatic Arthritis…